Kardigan, Inc.

Research Kardigan, Inc. (KARD) on Bullrun: market cap USD 1.97B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerKARD
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 1.97B
• Financial periodQ1 2026
• Net income-USD 56.07M
• Free cash flow-USD 59.41M

Valuation Snapshot

latest market cap is USD 1.97B.

About Kardigan, Inc.

Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of cardiovascular diseases, including primary and secondary cardiomyopathies leading to heart failure.

Frequently asked questions

What is Kardigan, Inc.'s market cap?

Kardigan, Inc.'s market capitalization is USD 1.97B.

What does Kardigan, Inc. do?

Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases. The company develops and provides a portfolio of medicines that target the underlying pathophysiology of cardiovascular diseases, including primary and secondary cardiomyopathies...